Name:	fate_AggregatePremiumOnSharesIssuedUnderCollaborativeArrangement
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The additional aggregate milestone payments that may be received by the entity based on the achievement of pre specified events under a collaborative arrangement.

No definition available.

Name:	fate_CollaborativeArrangementAdditionalAggregateMilestoneMethodPayments
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The aggregate milestone payments that may be received by the entity based on the achievement of pre specified events under a collaborative arrangement.

No definition available.

Name:	fate_CollaborativeArrangementAggregateMilestoneMethodPayments
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents the extended additional term of research under collaborative arrangements.

No definition available.

Name:	fate_CollaborativeArrangementExtendedAdditionalTermOfResearch
Namespace Prefix:	fate_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The amount of extension fee for additional term of research that may be received by the entity under a collaborative arrangement.

No definition available.

Name:	fate_CollaborativeArrangementExtensionFeeForAdditionalTerm
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

The minimum annual payments that may be received by the entity under a collaborative arrangement.

No definition available.

Name:	fate_CollaborativeArrangementMinimumAnnualPaymentsReceivable
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

The minimum annual payments for extended term of research that may be received by the entity under a collaborative arrangement.

No definition available.

Name:	fate_CollaborativeArrangementMinimumAnnualPaymentsReceivableForExtendedTermOfResearch
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Represents the agreed term of research under collaborative arrangements.

No definition available.

Name:	fate_CollaborativeArrangementTermOfResearch
Namespace Prefix:	fate_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the period of recognition of deferred revenue under collaborative arrangements.

No definition available.

Name:	fate_CollaborativeArrangementsDeferredRevenuePeriodOfRecognition
Namespace Prefix:	fate_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the term of royalties payable after first commercial sale of modulated product under collaborative arrangements.

No definition available.

Name:	fate_CollaborativeArrangementsTermOfRoyaltiesPayableAfterFirstCommercialSaleOfModulatedProduct
Namespace Prefix:	fate_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Represents the amount of upfront payments received under collaborative arrangements is recorded as deferred revenue.

No definition available.

Name:	fate_CollaborativeArrangementsUpfrontPaymentsRecordedUnderDeferredRevenue
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Represents value of common stock issued to the collaborative partners.

No definition available.

Name:	fate_CommonStockIssuedValueToCollaborativePartner
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Common stock premium percentage on trading price under collaborative arrangements upon exercise of extension option for research.

No definition available.

Name:	fate_CommonStockPremiumPercentageOnTradingPriceForCollaborativeArrangementsUponExerciseOfExtensionForResearch
Namespace Prefix:	fate_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Value of stock shares issuable to term under collaborative arrangement upon exercise of extension option for research.

No definition available.

Name:	fate_CommonStockSharesIssuableValueUponExerciseOfExtensionForResearchTermUnderCollaborativeArrangement
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Common stock trailing trading period considered for premium under collaborative arrangements upon exercise of extension option for research.

No definition available.

Name:	fate_CommonStockTrailingTradingPeriodConsideredForPremiumUnderCollaborativeArrangements
Namespace Prefix:	fate_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Per share amount of premium received for each share of common stock issued or sold in the stock transaction under collaborative arrangements.

No definition available.

Name:	fate_PremiumOnSharePricePerShareUnderCollaborativeArrangements
Namespace Prefix:	fate_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

Represents the cash inflow from the sale of common stock under collaborative arrangements.

No definition available.

Name:	fate_ProceedsFromSaleOfCommonStockUnderCollaborativeArrangements
Namespace Prefix:	fate_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Cash received from licensees for license fees during the current period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The amount of consideration recognized during the period for the milestone or milestones.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 28
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=68058744&loc=SL6892177-166501

Name:	us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Price of a single share of a number of saleable stocks of a company.

No definition available.

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

Number of new stock issued during the period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Name:	us-gaap_CounterpartyNameAxis=fate_JunoTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=fate_ThirdJunoProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ProductOrServiceAxis=fate_FifthJunoProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: